Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D Yang

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Clinical Genitourinary Cancer|December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active SurveillanceDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Implementing a context-augmented large language model to guide precision cancer medicineHyeji Jun, Yutaro Tanaka, Shreya Johri, et al.
Urologic Oncology|July 14, 2020
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation TherapyJames M G Tsui, Christopher E Kehayias, Jonathan E Leeman, et al.
Radiation Oncology (London, England)|August 18, 2020
Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancerDavid D Yang, Daniela L Buscariollo, Angel M Cronin, et al.
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate CancerDavid D Yang, Aya Abdelnaser, Jeremiah Wala, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Clinical Genitourinary Cancer|December 3, 2017
Pathologic Outcomes of Gleason 6 Favorable Intermediate-Risk Prostate Cancer Treated With Radical Prostatectomy: Implications for Active SurveillanceDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Implementing a context-augmented large language model to guide precision cancer medicineHyeji Jun, Yutaro Tanaka, Shreya Johri, et al.
Urologic Oncology|July 14, 2020
Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
International Journal of Radiation Oncology, Biology, Physics|July 30, 2023
Assessing the Feasibility of Using Artificial Intelligence-Segmented Dominant Intraprostatic Lesion for Focal Intraprostatic Boost With External Beam Radiation TherapyJames M G Tsui, Christopher E Kehayias, Jonathan E Leeman, et al.
Radiation Oncology (London, England)|August 18, 2020
Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancerDavid D Yang, Daniela L Buscariollo, Angel M Cronin, et al.
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
European Urology Focus|July 30, 2017
Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate CancerDavid D Yang, Aya Abdelnaser, Jeremiah Wala, et al.
Pageof 5